During the past decade, Metrolina Medical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 7 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metrolina Medical Research" #1 sponsor was "AstraZeneca" with 7 trials, followed by "Mannkind Corporation" with 2 trials sponsored, "Orexigen Therapeutics, Inc" with 2 trials sponsored, "Purdue Pharma LP" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metrolina Medical Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Metrolina Medical Research" are "Diabetes Mellitus, Type 2" (3 trials), "Back Pain Lower Back Chronic" (2 trials), "Obesity" (2 trials), "Overweight" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Metrolina Medical Research" in a lesser frequency.

Most popular intervention types in "Metrolina Medical Research" are "Drug" (24 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "AC2993" (3 trials), "placebo" (3 trials), "Ancillary therapy" (2 trials) and "Dapagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Metrolina Medical Research" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Metrolina Medical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Metrolina Medical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Metrolina Medical Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".